Request Deal Involvement
Merck completed the acquisition of VelosBio from Arix and Pappas Capital for $2.75bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Optimum Strategic Communications
legal advisors
Gibson Dunn & Crutcher
financial advisors
JP Morgan
legal advisors to financial advisors
Cravath Swaine & Moore
pr advisors
Gasthalter & Co
pr advisors
KKH Advisors
legal advisors
Cooley
financial advisors
Centerview Partners
or
Principals
vendor
ARIX BIOSCIENCE
bidder
MERCK & CO
vendor
PAPPAS CAPITAL
target
VELOSBIO INC
vendor
VENROCK
vendor
CHIESI VENTURES
vendor
ORBIMED ADVISORS LLC
vendor
TAKEDA VENTURES
vendor
SOFINNOVA PARTNERS
vendor
DECHENG CAPITAL LLC
vendor
FORESITE CAPITAL MANAGEMENT LLC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite